Abdelaziz M. Elhaddad

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Abdelaziz M. Elhaddad is an author at Massachusetts General Hospital specializing in pharmacotherapy, breast cancer hormone therapy, and breast cancer chemotherapy.

Publications per year

2023–2023

Publications

First-in-human phase 1/2a study of a potent and novel CDK2-selective inhibitor PF-07104091 in patients (pts) with advanced solid tumors, enriched for CDK4/6 inhibitor resistant HR+/HER2- breast cancer.

Timothy A. Yap, Abdelaziz M. Elhaddad, Rachel N. Grisham et al. · Journal of Clinical Oncology · 2023 · 56 citations

Medicine, Pharmacology, Pharmacotherapy +14

1–1 of 1